Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in TaxesDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amdocs (DOX) Other financing activities (2016 - 2018)

Historic Other financing activities for Amdocs (DOX) over the last 17 years, with Q3 2025 value amounting to $6.6 million.

  • Amdocs' Other financing activities fell 1010.96% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year increase of 7212.57%. This contributed to the annual value of $4.0 million for FY2025, which is 9990.85% down from last year.
  • As of Q3 2025, Amdocs' Other financing activities stood at $6.6 million, which was down 1010.96% from $4.5 billion recorded in Q2 2025.
  • Amdocs' Other financing activities' 5-year high stood at $4.5 billion during Q2 2025, with a 5-year trough of $1.8 million in Q3 2023.
  • For the 5-year period, Amdocs' Other financing activities averaged around $3.5 billion, with its median value being $4.1 billion (2022).
  • In the last 5 years, Amdocs' Other financing activities crashed by 9995.62% in 2023 and then skyrocketed by 30600.67% in 2024.
  • Over the past 5 years, Amdocs' Other financing activities (Quarter) stood at $4.0 billion in 2021, then rose by 4.18% to $4.1 billion in 2022, then rose by 3.74% to $4.3 billion in 2023, then grew by 3.96% to $4.5 billion in 2024, then plummeted by 99.85% to $6.6 million in 2025.
  • Its last three reported values are $6.6 million in Q3 2025, $4.5 billion for Q2 2025, and $4.5 billion during Q1 2025.